BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33686802)

  • 1. Analysis of seized peptide and protein-based doping agents using four complimentary methods: Liquid chromatography coupled with time of flight mass spectrometry, liquid chromatography-ultraviolet, Bradford, and immunoassays.
    Høj LJ; Rasmussen BS; Dalsgaard PW; Linnet K
    Drug Test Anal; 2021 Jul; 13(7):1457-1463. PubMed ID: 33686802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry.
    Vonaparti A; Lyris E; Angelis YS; Panderi I; Koupparis M; Tsantili-Kakoulidou A; Peters RJ; Nielen MW; Georgakopoulos C
    Rapid Commun Mass Spectrom; 2010 Jun; 24(11):1595-609. PubMed ID: 20486255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Applications and progresses of liquid chromatography-mass spectrometry in doping control].
    Qin Y; Xu Y; Yang S; Zhu S
    Se Pu; 2008 Jul; 26(4):431-6. PubMed ID: 18959237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography-quadrupole-time-of-flight mass spectrometry screening procedure for urine samples in forensic casework compared to gas chromatography-mass spectrometry.
    Fels H; Dame T; Sachs H; Musshoff F
    Drug Test Anal; 2017 May; 9(5):824-830. PubMed ID: 27373549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary human chorionic gonadotropin isoform concentrations in doping control samples.
    Butch AW; Woldemariam GA
    Drug Test Anal; 2016 Nov; 8(11-12):1147-1151. PubMed ID: 27594536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Black market products confiscated in Norway 2011-2014 compared to analytical findings in urine samples.
    Hullstein IR; Malerod-Fjeld H; Dehnes Y; Hemmersbach P
    Drug Test Anal; 2015; 7(11-12):1025-9. PubMed ID: 26607218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of liquid chromatography-mass spectrometry in doping control.
    Politi L; Groppi A; Polettini A
    J Anal Toxicol; 2005; 29(1):1-14. PubMed ID: 15808007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry.
    Kolmonen M; Leinonen A; Pelander A; Ojanperä I
    Anal Chim Acta; 2007 Feb; 585(1):94-102. PubMed ID: 17386652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Stimulants and Narcotics by Liquid Chromatography-Tandem Mass Spectrometry and Gas Chromatography-Mass Spectrometry for Sports Doping Control.
    Ahrens BD; Kucherova Y; Butch AW
    Methods Mol Biol; 2016; 1383():247-63. PubMed ID: 26660193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine reference intervals for human chorionic gonadotropin (hCG) isoforms by immunoextraction-tandem mass spectrometry to detect hCG use.
    Butch AW; Ahrens BD; Avliyakulov NK
    Drug Test Anal; 2018 Jun; 10(6):956-960. PubMed ID: 29098788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of new exemestane metabolites by liquid chromatography interfaced to electrospray-tandem mass spectrometry.
    de Albuquerque Cavalcanti G; Carius Garrido B; Dias Leal F; Costa Padilha M; Mazzarino M; de la Torre X; Botre F; Radler de Aquino Neto F
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):248-54. PubMed ID: 21924357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches.
    Sigmund G; Koch A; Orlovius AK; Guddat S; Thomas A; Schänzer W; Thevis M
    Drug Test Anal; 2014; 6(11-12):1197-205. PubMed ID: 24913825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and confirmation capabilities of liquid chromatography-time-of-flight mass spectrometry for the determination of 200 multiclass sport drugs in urine.
    Domínguez-Romero JC; García-Reyes JF; Lara-Ortega FJ; Molina-Díaz A
    Talanta; 2015 Mar; 134():74-88. PubMed ID: 25618643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro metabolism studies on the selective androgen receptor modulator (SARM) LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry.
    Knoop A; Krug O; Vincenti M; Schänzer W; Thevis M
    Eur J Mass Spectrom (Chichester); 2015; 21(1):27-36. PubMed ID: 25906032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of cobalt for human sports drug testing purposes using ICP- and LC-ICP-MS.
    Knoop A; Planitz P; Wüst B; Thevis M
    Drug Test Anal; 2020 Nov; 12(11-12):1666-1672. PubMed ID: 33142033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive study on the performance of different retention mechanisms in sport drug testing by liquid chromatography tandem mass spectrometry.
    González-Rubio S; Ballesteros-Gómez A; Carreras D; Muñoz G; Rubio S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jul; 1178():122821. PubMed ID: 34229166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multianalyte LC-MS-based methods in doping control: what are the implications for doping athletes?
    Botrè F; de la Torre X; Mazzarino M
    Bioanalysis; 2016 Jun; 8(11):1129-32. PubMed ID: 27212276
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of a mass spectrometry based detection method for the mitochondrion-derived peptide MOTS-c in plasma samples for doping control purposes.
    Knoop A; Thomas A; Thevis M
    Rapid Commun Mass Spectrom; 2019 Feb; 33(4):371-380. PubMed ID: 30394592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.